Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient

This study has been completed.
Information provided by:
University Hospital, Ghent Identifier:
First received: February 1, 2006
Last updated: February 17, 2009
Last verified: February 2009
To prospectively obtain data about the clinical and radiological results of the resurfacing technique as primary hip prosthesis in young active patients

Condition Intervention
Indications for a Total Hip Prosthesis
Device: Primary Birmingham hip resurfacing arthroplasty using a metal-on-metal couple

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Clinical and radiological results

Estimated Enrollment: 250
Study Start Date: November 1998
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Total hip prosthesis

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00285948

University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: René Verdonk, University Hospital Ghent Identifier: NCT00285948     History of Changes
Other Study ID Numbers: 2004/339 
Study First Received: February 1, 2006
Last Updated: February 17, 2009
Health Authority: Belgium: Institutional Review Board processed this record on October 20, 2016